THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Drug Administration Schedule

This is a "connection" page, showing publications Udho Thadani has written about Drug Administration Schedule.
Connection Strength

0.365
  1. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes. Am J Cardiovasc Drugs. 2009; 9(3):211-2; author reply 212.
    View in: PubMed
    Score: 0.077
  2. Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction. Am J Cardiovasc Drugs. 2005; 5(5):331-4.
    View in: PubMed
    Score: 0.058
  3. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group. Circulation. 1994 Aug; 90(2):726-34.
    View in: PubMed
    Score: 0.028
  4. Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol. 1994 Jul 01; 74(1):9-17.
    View in: PubMed
    Score: 0.028
  5. Duration of effects of isradipine during twice daily therapy in angina pectoris. Cardiovasc Drugs Ther. 1994 Apr; 8(2):199-210.
    View in: PubMed
    Score: 0.028
  6. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann Intern Med. 1994 Mar 01; 120(5):353-9.
    View in: PubMed
    Score: 0.028
  7. Efficacy of isosorbide mononitrate in angina pectoris. Am J Cardiol. 1992 Nov 27; 70(17):67G-71G.
    View in: PubMed
    Score: 0.025
  8. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris. Am J Cardiol. 1992 Aug 01; 70(3):286-92.
    View in: PubMed
    Score: 0.025
  9. Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group. Am Heart J. 1989 Nov; 118(5 Pt 2):1135.
    View in: PubMed
    Score: 0.020
  10. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris. Am J Cardiol. 1987 Sep 01; 60(7):477-82.
    View in: PubMed
    Score: 0.018
  11. Assessment of "optimal" beta blockade in treating patients with angina pectoris. Acta Med Scand Suppl. 1985; 694:178-87.
    View in: PubMed
    Score: 0.015
  12. Beta adrenergic blocking agents for exertional angina pectoris. Herz. 1982 Jun; 7(3):179-87.
    View in: PubMed
    Score: 0.012
  13. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. Am J Cardiol. 1981 May; 47(5):1123-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES